GoldsteinDJWangOSaperJRStoltzRSilbersteinSDMathewNT.Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study.
Cephalagia1997;
17:
785–90
2.
MoskowitzMA.Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
Trends Pharmacol Sci1992;
13:
307–11
3.
DienerHCHartungGoelBeckmannLangohrKlapperKudrowLMathewNTSaperJRSilbersteinSD.Substance-P antagonist RPR 100893-0201 is not effective in human migraine attacks.
6th International Headache Research Seminar,
November 1995;
63
4.
WatsonJWGonsalvesSFFossaAAMcLeanSSeegerTObachSAndrewsPL.The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
Br J Pharmacol1995;
15:
84–94
5.
StrassmanAMRaymondSABursteinR.Sensitization of meningeal sensory neurons and the origin of headache.
Nature1996;
84:
560–4
6.
MatsubaraTMoskowitzMAHuangZ.UK-14, 304, R(-)–methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms.
Eur J Pharmacol1992;
224:
145–50
7.
MoskowitzMAWaeberC.Migraine enters the molecular era.
Neuroscientist1996;
2:
191–200
